{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:16:47Z","timestamp":1780676207935,"version":"3.54.1"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["54\/08\/2019\/HUM-BMS"],"award-info":[{"award-number":["54\/08\/2019\/HUM-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2019-1384"],"award-info":[{"award-number":["2019-1384"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["SR\/FST\/LS-I\/2017\/49-C"],"award-info":[{"award-number":["SR\/FST\/LS-I\/2017\/49-C"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.reprotox.2021.06.005","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T04:42:43Z","timestamp":1623386563000},"page":"124-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Potential environmental toxicant exposure, metabolizing gene variants and risk of PCOS-A systematic review"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3018-1637","authenticated-orcid":false,"given":"Priya","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5577-2444","authenticated-orcid":false,"given":"Nisha","family":"Bilkhiwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-3249","authenticated-orcid":false,"given":"Pragya","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6883-7788","authenticated-orcid":false,"given":"Sachin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0510-3370","authenticated-orcid":false,"given":"Preeti","family":"Khetarpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2021.06.005_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph15112589","article-title":"Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity","volume":"15","author":"Wolf","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0010","first-page":"1","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"20","author":"Pate","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0015","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16224446","article-title":"It\u2019s time to replace the term \u201cheavy metals\u201d with \u201cpotentially toxic elements\u201d when reporting environmental research","volume":"16","author":"Pourret","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0025","doi-asserted-by":"crossref","DOI":"10.4103\/ijpvm.IJPVM_576_17","article-title":"Oxidative stress and polycystic ovary syndrome: a brief review","volume":"10","author":"Mohammadi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-018-0391-5","article-title":"A novel and compact review on the role of oxidative stress in female reproduction","volume":"16","author":"Lu","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.taap.2013.01.025","article-title":"Pesticides and human chronic diseases: evidences, mechanisms, and perspectives","volume":"268","author":"Mostafalou","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0040","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/JOE-17-0023","article-title":"Exposure to endocrine disruptors during adulthood: consequences for female fertility","volume":"233","author":"Rattan","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/10807039.2013.788972","article-title":"Effects of environmental pesticides on the health of rural communities in the Malwa Region of Punjab, India: a review","volume":"20","author":"Mittal","year":"2014","journal-title":"Hum. Ecol. Risk Assess."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0050","article-title":"Potential health risk and levels of heavy metals in water resources of lead\u2013zinc mining communities of Abakaliki, southeast Nigeria","volume":"184","author":"Obasi","year":"2020","journal-title":"Appl. Water Sci."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: an update","volume":"16","author":"De Leo","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0060","article-title":"Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article","volume":"3","author":"Ajmal","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12011-012-9592-5","article-title":"Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome","volume":"152","author":"Chakraborty","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejogrb.2013.01.021","article-title":"Plasma selenium levels in Turkish women with polycystic ovary syndrome","volume":"168","author":"Coskun","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0080","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/0960327111424299","article-title":"Serum trace elements and heavy metals in polycystic ovary syndrome","volume":"31","author":"Kurdoglu","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/09513590.2013.774361","article-title":"The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome","volume":"3590","author":"Celik","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12011-014-9941-7","article-title":"Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance","author":"Guler","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12011-015-0294-7","article-title":"Association of serum heavy metals and trace element concentrations with reproductive hormone levels and polycystic ovary syndrome in a chinese population","volume":"167","author":"Zheng","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.5603\/GP.2016.0079","article-title":"Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome","volume":"87","author":"\u00d6zer","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0105","first-page":"39","article-title":"Assessment of serum zinc level in patients with polycystic ovary syndrome","volume":"15","author":"Farhood","year":"2017","journal-title":"Iraqi J. Med. Sci."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5114\/amscd.2017.66840","article-title":"Metabolic syndrome assessment of the relationship between serum vitamin (A, B 12, C, D, folate) and zinc levels and polycystic ovary syndrome","volume":"2","author":"Kulhan","year":"2017","journal-title":"Arch. Med. Sci. Civil Dis."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12011-016-0782-4","article-title":"Serum macroelement and microelement concentrations in patients with polycystic ovary syndrome: a cross-sectional study","author":"Li","year":"2017","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.24237\/djps.1401.366A","article-title":"Evaluation of zinc, copper, chromium and thyroid hormones levels in serum of Iraqi women with polycystic ovarian syndrome","volume":"14","author":"Mahdi","year":"2018","journal-title":"DJPS."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12011-017-1000-8","article-title":"Serum level of zinc and copper in sudanese women with polycystic ovarian syndrome","volume":"180","author":"Sharif","year":"2017","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtemb.2017.08.012","article-title":"Selenium status parameters in patients with polycystic ovary syndrome","volume":"44","author":"Zagrodzki","year":"2017","journal-title":"J. Trace. Elem. Biol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mefs.2017.11.003","article-title":"Status of serum selenium and zinc in patients with the polycystic ovary syndrome with and without insulin resistance","volume":"23","author":"Kanafchian","year":"2018","journal-title":"Middle East Fertil. Soc. J."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12011-019-01705-7","article-title":"Status of serum copper, magnesium, and total antioxidant capacity in patients with polycystic ovary syndrome","volume":"193","author":"Kanafchian","year":"2019","journal-title":"Biol. Trace. Elem. Res"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.26453\/otjhs.571510","article-title":"The relationship between insulin resistance and trace elements in patients with polycystic ovary syndrome","volume":"5","author":"Balahoroglu","year":"2020","journal-title":"OTJHS"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0150","first-page":"12","article-title":"The role of Irisin, copper and zinc levels on insulin resistance in polycystic ovary syndrome","volume":"1","author":"Mustafa","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0155","first-page":"1","article-title":"Some altered trace elements in patients with polycystic ovary syndrome","author":"Al-Jeborry","year":"2017","journal-title":"J. adv. med."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.33545\/gynae.2020.v4.i1b.446","article-title":"Serum levels of zinc, copper and magnesium in polycystic ovarian syndrome: a cross sectional study","volume":"4","author":"Nanda","year":"2020","journal-title":"Int. J. Clin. Obstet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6823-14-86","article-title":"Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case-control study","volume":"14","author":"Vagi","year":"2014","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.chemosphere.2016.12.127","article-title":"Association of serum organochlorine pesticides concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population","volume":"171","author":"Guo","year":"2017","journal-title":"Chemosphere"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0175","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/humrep\/dev123","article-title":"Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study","volume":"30","author":"Yang","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0180","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ijheh.2018.07.009","article-title":"Perfluorinated alkyl acids in the serum and follicular fluid of UK women with and without polycystic ovarian syndrome undergoing fertility treatment and associations with hormonal and metabolic parameters","volume":"221","author":"Heffernan","year":"2018","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0185","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtemb.2019.01.002","article-title":"Zinc status and polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"52","author":"Abedini","year":"2019","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/a-0890-6823","article-title":"Selenium and polycystic ovary syndrome; current knowledge and future directions: a systematic review","volume":"51","author":"Hajizadeh-Sharafabad","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fertnstert.2016.05.011","article-title":"Environmental determinants of polycystic ovary syndrome","volume":"106","author":"Merkin","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2167-0250.1000129","article-title":"Genetic polymorphism of CYP1A1 (T6235C) gene as a risk factor for polycystic ovary syndrome","volume":"04","author":"Priyanka Pandey","year":"2015","journal-title":"Andrology-Open Access."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0205","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1472-6483(10)62129-3","article-title":"CYP1A1, GSTM1 and GSTT1 genetic polymorphism is associated with susceptibility to polycystic ovaries in South Indian women","volume":"9","author":"Babu","year":"2004","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1472-6483(10)60596-2","article-title":"CYP1A1 gene polymorphism and polycystic ovary syndrome","volume":"16","author":"Esinler","year":"2008","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0215","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity","volume":"89","author":"San Mill\u00e1n","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0220","first-page":"3346","article-title":"Effect of paraoxonase gene polymorphisms on paraoxonase levels and insulin resistance index in women with polycystic ovary syndrome","volume":"3","author":"Mohamed","year":"2009","journal-title":"Aust. J. Basic Appl. Sci."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cen.12139","article-title":"PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia","volume":"79","author":"Paltoglou","year":"2013","journal-title":"Clin. Endocrino."},{"issue":"May (20)","key":"10.1016\/j.reprotox.2021.06.005_bib0230","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1055\/s-0029-1222564","article-title":"[Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome]","volume":"134","author":"Knebel","year":"2009","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gene.2018.03.083","article-title":"PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women","volume":"661","author":"Dadachanji","year":"2018","journal-title":"Gene."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/EJE-14-0863","article-title":"Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome","volume":"172","author":"Zhang","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0245","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/bmm-2018-0271","article-title":"Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis","volume":"13","author":"Nalkiran","year":"2019","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0250","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1530\/EJE-11-0986","article-title":"Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in south-west Chinese women","volume":"166","author":"Wang","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2015.03.037","article-title":"PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome","volume":"104","author":"Dadachanji","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0260","first-page":"173","article-title":"Association between serum paraoxonase 1 activities (PONase\/AREase) and L55M polymorphism in risk of female infertility","volume":"7","author":"Motovali-Bashi","year":"2015","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0265","article-title":"Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women","author":"Liu","year":"2019","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00771","article-title":"Association of GPx1 P198L and CAT C-262T genetic variations with polycystic ovary syndrome in chinese women","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/0974-1208.97802","article-title":"MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome","volume":"5","author":"Jain","year":"2012","journal-title":"J. Hum. Reprod. Sci."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2018.00504","article-title":"Variant alleles of the ESR1, PPARG, HMGA2, and MTHFR genes are associated with polycystic ovary syndrome risk in a Chinese population: a case-control study","volume":"9","author":"Jiao","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0285","first-page":"229","article-title":"Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in women with polycystic ovary syndrome in southeast of Iran","volume":"8","author":"Naghavi","year":"2015","journal-title":"J. Med. Life"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0290","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/17.2.314","article-title":"Polycystic ovarian syn- drome and thrombophilia","volume":"17","author":"Tsanadis","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0295","first-page":"217","article-title":"The study of 5,10-methylenetetrahydrofolate reductase variation (MTHFR C677T) in infertile females with polycystic ovarian syndrome (PCOS) in Korea","volume":"30","author":"Lee","year":"2003","journal-title":"Kor. J. Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/14647270600950157","article-title":"Polycystic ovary syndrome and the single nucleotide polymorphisms of methylenetetrahydrofolate reductase: a pilot observational study","volume":"10","author":"Palep-Singh","year":"2007","journal-title":"Hum. Fertil. (Camb.)"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12020-010-9370-0","article-title":"Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome","volume":"38","author":"Karadeniz","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0310","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/aji.12002","article-title":"Plasminogen acti- vator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in Iranian women with polycystic ovary syndrome","volume":"68","author":"Idali","year":"2012","journal-title":"Am. J. Reprod. Immunol. Microbiol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0315","first-page":"400","article-title":"Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome","volume":"32","author":"Qi","year":"2015","journal-title":"Chin. J. Med. Genet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0320","doi-asserted-by":"crossref","DOI":"10.4238\/gmr15048570","article-title":"Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk","volume":"15","author":"Wu","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0325","doi-asserted-by":"crossref","first-page":"246","DOI":"10.17772\/gp\/61751","article-title":"Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism?","volume":"87","author":"O\u017cegowska","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0330","first-page":"366","article-title":"Glutathione S-transferase (GST) polymorphism could be an early marker in the development of polycystic ovary syndrome (PCOS)\u2014an insight from non-obese and non-insulin resistant adolescents","volume":"69","author":"Savic-Radojevic","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0335","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3889\/oamjms.2017.088","article-title":"Association of the Pro12Ala polymorphism with the metabolic parameters in women with polycystic ovary syndrome","volume":"5","author":"Zaki","year":"2017","journal-title":"Maced. J. Med. Sci."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0340","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.gene.2012.04.060","article-title":"Polymorphisms in the IRS \u2010 1 and PPAR- \u03b3 genes and their association with polycystic ovary syndrome among South Indian women","volume":"503","author":"Dasgupta","year":"2012","journal-title":"Gene."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0345","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1472-6483(10)60008-9","article-title":"Pro12Ala and His447His polymorphisms of PPAR-gamma are associated with polycystic ovary syndrome","volume":"18","author":"Gu","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0350","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/humrep\/deg128","article-title":"Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome","volume":"18","author":"Korhonen","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0355","first-page":"147","article-title":"The association of PPAR\u03b3 Pro12Ala and C161T polymorphisms with polycystic ovary syndrome and their influence on lipid and lipoprotein profiles","volume":"12","author":"Rahimi","year":"2018","journal-title":"Int. J. Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0360","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10815-013-0025-y","article-title":"Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome","volume":"30","author":"Shaikh","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0365","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/09513590600733357","article-title":"Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome","volume":"22","author":"Yilmaz","year":"2006","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0370","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-\u03b3 polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0375","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1744-313X.2009.00867.x","article-title":"The relationship of the interleukin-6-174 G&C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients","volume":"36","author":"Erdogan","year":"2009","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0380","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s10815-013-0111-1","article-title":"An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women","volume":"30","author":"Tumu","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0385","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1744-313X.2009.00867.x","article-title":"The relationship of the interleukin-6-174 G&C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients","volume":"36","author":"Erdogan","year":"2009","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2010.02.010","article-title":"Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome","volume":"150","author":"Vural","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0395","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10815-009-9308-8","article-title":"Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome","author":"Unsal","year":"2009","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0400","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-009-9205-z","article-title":"Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese","volume":"36","author":"Wang","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0405","first-page":"24","article-title":"The \u2212108C\/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome","volume":"42","author":"Zhang","year":"2011","journal-title":"J. S.i Chuan. Univ. (Med Sci Edi)"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0410","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3892\/br.2013.214","article-title":"Association of \u2011 108 C & T PON1 polymorphism with polycystic ovary syndrome","volume":"2","author":"Ferk","year":"2014","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0415","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/09513591003686387","article-title":"The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome","volume":"26","author":"Lenarcik","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2009.04.013","article-title":"Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome","volume":"145","author":"Choi","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1447-0756.2001.tb01241.x","article-title":"Plasma homocysteine, fasting insulin, and androgen patterns among women with polycystic ovaries and infertility","volume":"27","author":"Sills","year":"2001","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0430","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2002-021142","article-title":"Homocysteine levels and C677T poly- morphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0435","doi-asserted-by":"crossref","first-page":"246","DOI":"10.17772\/gp\/61751","article-title":"Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism?","volume":"87","author":"Ozegowska","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0440","first-page":"141","article-title":"Methylenotetrahydrololate reductase A1298C and C677T polymorphisms and adverse pregnancy outcome in women with PCOS","volume":"37","author":"Szafarowska","year":"2016","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151510","article-title":"Is MTHFR 677 C & Tpolymorphism clinically important in polycystic ovarian syndrome (PCOS)? A case- control study, meta-analysis and trial sequential analysis","volume":"11","author":"Carlus","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0450","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcma.2013.01.009","article-title":"Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: a comparative study","volume":"76","author":"Kazerooni","year":"2013","journal-title":"J. Chinese Med. Assoc."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0455","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.2009.03679.x","article-title":"The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case\u2013control study followed by systematic review and meta-analysis of existing evidence","volume":"72","author":"San-Mill\u00e1n","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0460","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.fertnstert.2006.10.006","article-title":"Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome","volume":"87","author":"Antoine","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0465","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3892\/br.2013.215","article-title":"Association of Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome","volume":"2","author":"Baldani","year":"2014","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0470","first-page":"426","article-title":"Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome","volume":"82","author":"Bidzi\u0144ska-Speichert","year":"2011","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000279309","article-title":"Peroxisome proliferator-activated receptor-gamma and its coactivator1alpha gene polymorphisms in Korean women with polycystic ovary syndrome","volume":"70","author":"Chae","year":"2010","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0480","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1749-6632.2010.05647.x","article-title":"Peroxisome proliferator-activated receptor-gamma and -delta polymorphisms in women with polycystic ovary syndrome","author":"Christopoulos","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0485","first-page":"1","article-title":"Influence of peroxisome proliferator-activated receptor-\u03b3 exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome","volume":"13","author":"Giandalia","year":"2018","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0490","first-page":"25","article-title":"A common 34C&G variant at the peroxisome proliferator-activated receptor-2 gene in Chilean women with polycystic ovary syndrome and controls","author":"Guzman","year":"2007","journal-title":"Int. J. Morphol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0495","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-2005-837665","article-title":"Genetic determinants of insulin action in polycystic ovary syndrome","volume":"113","author":"Haap","year":"2005","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0500","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2265.2005.02261.x","article-title":"The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome","volume":"62","author":"Hahn","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0505","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-2008-1058085","article-title":"Increased low grade inflammatory serum markers in patients with polycystic ovary syndrome (PCOS) and their relationship to PPAR\u03b3 gene variants","volume":"116","author":"Knebel","year":"2008","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0510","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/EJE-08-1014","article-title":"Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome","volume":"161","author":"Koika","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0515","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/humrep\/deh769","article-title":"Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype","volume":"20","author":"Tok","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0520","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.fertnstert.2005.10.047","article-title":"Polymorphisms of the peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha genes in Chinese women with polycystic ovary syndrome","volume":"85","author":"Wang","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0525","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF03401274","article-title":"The Pro12Ala polymorphism of the PPAR-gamma gene is not associated with the polycystic ovary syndrome","volume":"8","author":"Xita","year":"2009","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0530","first-page":"1894","article-title":"The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome","volume":"6","author":"Yang","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0535","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2004-0109","article-title":"Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0540","first-page":"692","article-title":"Peroxisome proliferator-activated receptor-\u03b32 gene pro12Ala polymorphisms cannot predict ovarian reproductive function through rosiglitazone in women with polycystic ovarian syndrome","author":"Zheng","year":"2008","journal-title":"J. Xi\u2019an Jiaotong Univ. (Med. Sci.)"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0545","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12041-017-0749-z","article-title":"Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome","volume":"96","author":"Thangavelu","year":"2017","journal-title":"J. Genet."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0550","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.fertnstert.2004.01.021","article-title":"A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome","volume":"81","author":"Walch","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0555","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/01443615.2016.1256966","article-title":"The effects of IL-1A and IL-6 genes polymorphisms on gene expressions, hormonal and biochemical parameters in polycystic ovary syndrome","volume":"37","author":"Eser","year":"2017","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0005606","article-title":"Role of haptoglobinin polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women","volume":"4","author":"\u00c1lvarez-Blasco","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0565","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/jcm8101606","article-title":"The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies","volume":"8","author":"Hiam","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0570","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/reveh-2018-0045","article-title":"Exposure to environmental toxicants and young children\u2019s cognitive and social development","volume":"34","author":"Davis","year":"2019","journal-title":"Rev. Environ. Health"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0575","series-title":"Framework for Metals Risk Assessment","author":"EPA","year":"2007"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0580","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/01480545.2017.1320405","article-title":"The impact of exposure route for class-based compounds: a comparative approach of lethal toxicity data in rodent models","volume":"41","author":"Wang","year":"2018","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13530-015-0216-2","article-title":"Occupational exposure to chemicals and oxidative toxic stress","volume":"7","author":"Soleimani","year":"2015","journal-title":"Toxicol. Environ. Health Sci."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0590","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8589318","article-title":"Roles of oxidative stress in polycystic ovary syndrome and cancers","author":"Zuo","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0595","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0015-0282(03)00266-8","article-title":"Oxidative stress may be a piece in the endometriosis puzzle","volume":"79","author":"Szczepa\u0144ska","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0600","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/humrep\/deg415","article-title":"Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells","volume":"18","author":"Albrecht","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-017-0308-5","article-title":"The role of Notch signalling in ovarian angiogenesis","volume":"10","author":"Xie","year":"2017","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0610","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1073\/pnas.1017213108","article-title":"Reactive oxygen species are indispensable in ovulation","volume":"108","author":"Shkolnik","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0615","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.fertnstert.2005.07.1316","article-title":"Usefulness of intraovarian artery pulsatility and resistance indices measurement on the day of follicle aspiration for the assessment of oocyte quality","volume":"85","author":"Du","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0620","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.18632\/oncotarget.22153","article-title":"MAPK and ERK polymorphisms are associated with PCOS risk in Chinese women","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0625","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","article-title":"The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance","volume":"89","author":"Bremer","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0630","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.fertnstert.2004.10.057","article-title":"Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome","volume":"83","author":"Premoli","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0635","first-page":"142","article-title":"the effects of calcium -vitamin d and metformin on polycystic ovary syndrome: Taiwan","volume":"48","author":"Rashidi","year":"2009","journal-title":"J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2014.04.009","article-title":"A review on the molecular mechanisms involved in insulin resistance induced by organophosphorus pesticides","volume":"322","author":"Lasram","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0645","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0303-7207(02)00423-9","article-title":"Dual activation of PPAR\u03b1 and PPAR\u03b3 by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells","volume":"201","author":"Lovekamp-Swan","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0650","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1507\/endocrj.51.165","article-title":"Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction","volume":"51","author":"Takeuchi","year":"2004","journal-title":"Endocr. J."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0116057","article-title":"Persistent organic pollutants and early menopause in U.S. Women","volume":"10","author":"Grindler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0660","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.taap.2014.02.009","article-title":"In utero bisphenol A exposure disrupts germ cell nest breakdown and reduces fertility with age in the mouse","volume":"276","author":"Wang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0665","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40557-017-0162-3","article-title":"Pesticide metabolite and oxidative stress in male farmers exposed to pesticide","volume":"29","author":"Lee","year":"2017","journal-title":"Ann. Occup. Environ. Med."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0675","article-title":"Redox toxicology of environmental chemicals causing oxidative stress","volume":"18","author":"Zheng","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0680","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.forsciint.2005.05.034","article-title":"Autosomal microsatellite data from Northwestern Colombia","volume":"160","author":"Palacio","year":"2006","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0685","series-title":"In Polycystic Ovarian Syndrome","article-title":"Clinical features of PCOS","author":"Alsadi","year":"2019"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0690","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/1-59745-107-X_5","article-title":"Heavy metals as endocrine-disrupting chemicals","author":"Dyer","year":"2007","journal-title":"Endocrine-Disrupting Chem."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0695","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.fertnstert.2016.08.031","article-title":"Polycystic ovary syndrome and environmental toxins","volume":"106","author":"Rutkowska","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0700","first-page":"165","article-title":"Metabolism of pesticides by human cytochrome P450 enzymes in vitro\u2013a survey","volume":"5","author":"Abass","year":"2012","journal-title":"Insecticides\u2014Adv. Integr. Pest Manage."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.143997","article-title":"Identification of structural properties influencing the metabolism of polycyclic aromatic hydrocarbons by cytochrome P450 1A1","volume":"758","author":"Chen","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0710","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.pharmtox.45.120403.100010","article-title":"Cytochrome P450 activation of arylamines and heterocyclic amines","volume":"45","author":"Kim","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0019-5278.146900","article-title":"cytochrome, carcinogenesis: a topic in preventive toxicology","volume":"18","author":"Benzene","year":"2014","journal-title":"Indian J. Occup. Environ. Med."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108642","article-title":"The impact of genetic variation on metabolism of heavy metals: genetic predisposition?","volume":"113","author":"Joneidi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092152","article-title":"Association of cadmium, lead and mercury with paraoxonase 1 activity in women","volume":"9","author":"Pollack","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0162-0134(02)00627-X","article-title":"Inhibition of human serum arylesterase by metal chlorides","volume":"94","author":"Debord","year":"2003","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0735","doi-asserted-by":"crossref","DOI":"10.5772\/14020","article-title":"Organophosphorous pesticides - mechanisms of their toxicity","author":"Elersek","year":"2011","journal-title":"Pestic. - Impacts Pestic. Expo."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0740","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/15376516.2011.557878","article-title":"Epigenetic mechanisms in metal toxicity","volume":"21","author":"Fragou","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-019-0356-5","article-title":"Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer","volume":"19","author":"Jiao","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0442-y","article-title":"Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis","volume":"10","author":"Pan","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0755","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1080\/09513590.2016.1203409","article-title":"The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations","volume":"32","author":"Li","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0760","doi-asserted-by":"crossref","DOI":"10.19080\/AIBM.2018.09.555760","article-title":"Environmental metals as DNA stressor and epigenetic modulator","volume":"9","author":"Okoh","year":"2018","journal-title":"Adv Biotech & Micro."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0765","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4161\/epi.6.7.16250","article-title":"Environmental epigenetics in metal exposure","volume":"6","author":"Martinez-Zamudio","year":"2011","journal-title":"Epigenetics."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0770","doi-asserted-by":"crossref","first-page":"20654","DOI":"10.1007\/s11356-019-05345-1","article-title":"Copper(II) generates ROS and RNS, impairs antioxidant system and damages membrane and DNA in human blood cells","volume":"26","author":"Husain","year":"2019","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0775","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1039\/b903049b","article-title":"Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium","volume":"3","author":"Arita","year":"2009","journal-title":"Metallomics."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0780","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.chemosphere.2018.03.062","article-title":"Interactions between chromium(III) and iron(III), molybdenum(III) or nickel(II): cytotoxicity, genotoxicity and mutagenicity studies","volume":"201","author":"Terpilowska","year":"2018","journal-title":"Chemosphere"},{"key":"10.1016\/j.reprotox.2021.06.005_bib0785","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bcpt.13424","article-title":"DNA methylation level in blood and relations to breast cancer, risk factors and environmental exposure in Greenlandic Inuit women","volume":"127","author":"Wiels\u00f8e","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0790","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.scitotenv.2018.07.143","article-title":"Organophosphate pesticide exposure and differential genome-wide DNA methylation","volume":"645","author":"Paul","year":"2018","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0795","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.envint.2018.06.039","article-title":"Prenatal exposure to persistent organic pollutants and methylation of LINE-1 and imprinted genes in placenta: a CHECK cohort study","volume":"119","author":"Kim","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.reprotox.2021.06.005_bib0800","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-0034-1371088","article-title":"Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?","volume":"32","author":"Barrett","year":"2014","journal-title":"Semin. Reprod. Med."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623821000903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623821000903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:09:05Z","timestamp":1778504945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623821000903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":160,"alternative-id":["S0890623821000903"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.06.005","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential environmental toxicant exposure, metabolizing gene variants and risk of PCOS-A systematic review","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}